miR-26a also increased IFN-α expression by targeting ubiquitin-specific protease 3 (USP3), which is a negative regulator of IFN-α [49], suggesting that IFN-α and miR-26a inhibit the development of HCC by forming positive feedback loops. Here, USP3 is linked to hepatocellular carcinoma.